Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.12 trillion and total revenue of $109.95 billion.
Market Cap
1.12T
Revenue
109.95B
Profits
-41.78B
PE Ratio
n/a
Profit Margin
-38.00%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.81B | 8.31% | 3,363,818 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.23B | -1.22% | 473,423 | 14.34B |
| 3 | ARGX | argenx SE | 45.56B | 0.32% | 340,825 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.76B | -0.37% | 1,169,418 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.88B | 1.03% | 144,419 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.01B | 0.50% | 1,147,844 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.52B | 0.28% | 2,395,288 | 2.38B |
| 8 | MRNA | Moderna, Inc. | 21.71B | -1.36% | 7,268,726 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 21.26B | 0.58% | 5,314,066 | 13.31M |
| 10 | BNTX | BioNTech SE | 21.05B | -17.88% | 12,523,157 | 3.37B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.59B | -0.93% | 2,104,308 | - |
| 12 | INCY | Incyte Corporation | 19.11B | -1.11% | 1,547,972 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.15B | 2.64% | 1,844,929 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.76B | 0.25% | 349,046 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.41B | 13.22% | 6,157,472 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.66B | 3.88% | 2,974,210 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.50B | 0.40% | 2,785,714 | 943.71M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.71B | 0.02% | 1,235,163 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.45B | 0.29% | 1,135,363 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.72B | -2.55% | 4,073,360 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.93B | -0.10% | 254,465 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.00B | 5.17% | 543,771 | 6.23M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.63B | 0.29% | 417,280 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.51B | 1.12% | 423,902 | 638.50M |
| 25 | PCVX | Vaxcyte, Inc. | 8.38B | -1.82% | 805,564 | - |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.29B | -2.42% | 2,174,622 | 1.09B |
| 27 | TECH | Bio-Techne Corporation | 8.26B | -3.74% | 2,778,516 | 1.22B |
| 28 | IBRX | ImmunityBio, Inc. | 8.24B | -5.21% | 24,405,209 | 113.29M |
| 29 | NUVL | Nuvalent, Inc. | 8.04B | -0.06% | 549,619 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.00B | -0.48% | 1,353,732 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.91B | 2.85% | 2,114,563 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.63B | 0.94% | 227,047 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.91B | -0.54% | 601,528 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.85B | -2.86% | 179,990 | - |
| 35 | ACLX | Arcellx, Inc. | 6.71B | -0.10% | 2,595,147 | 22.29M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.35B | 0.01% | 482,460 | 189.76M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.19B | 0.40% | 856,025 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.91B | -0.89% | 1,183,555 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.68B | 0.23% | 1,025,111 | 1.73B |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 5.49B | 2.42% | 768,713 | 521.31M |
| 41 | CELC | Celcuity Inc. | 5.42B | 3.22% | 701,968 | - |
| 42 | CGON | CG Oncology, Inc. | 5.30B | 2.46% | 1,436,172 | 4.04M |
| 43 | CAI | Caris Life Sciences, Inc. | 5.24B | -2.42% | 1,755,279 | 812.03M |
| 44 | IMVT | Immunovant, Inc. | 5.23B | -2.61% | 1,186,232 | - |
| 45 | APGE | Apogee Therapeutics, Inc. | 5.19B | 0.57% | 793,587 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.14B | 1.24% | 1,841,051 | - |
| 47 | CRSP | CRISPR Therapeutics AG | 5.07B | -10.17% | 9,434,588 | 3.51M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.04B | -3.43% | 3,758,302 | 7.50M |
| 49 | TERN | Terns Pharmaceuticals, Inc. | 4.93B | 2.26% | 2,219,214 | - |
| 50 | ERAS | Erasca, Inc. | 4.82B | -1.14% | 5,073,572 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.51B | -0.07% | 3,349,632 | 634.21M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.32B | 0.27% | 1,118,521 | 616.29M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.23B | 1.98% | 275,352 | 268.09M |
| 54 | GPCR | Structure Therapeutics Inc. | 4.12B | 3.04% | 932,860 | - |
| 55 | CNTA | Centessa Pharmaceuticals plc | 4.03B | 5.75% | 1,480,774 | 15.00M |
| 56 | VKTX | Viking Therapeutics, Inc. | 4.01B | 3.12% | 2,978,804 | - |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.91B | -2.28% | 1,015,619 | 7.70M |
| 58 | DNTH | Dianthus Therapeutics, Inc. | 3.87B | 9.71% | 2,327,667 | 2.04M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.84B | -0.18% | 1,251,949 | 1.07B |
| 60 | ADMA | ADMA Biologics, Inc. | 3.77B | 0.13% | 2,159,242 | 510.17M |
| 61 | LEGN | Legend Biotech Corporation | 3.61B | 2.19% | 1,626,060 | 1.03B |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.60B | 1.62% | 1,016,200 | 22.50M |
| 63 | CORT | Corcept Therapeutics Incorporated | 3.57B | -1.32% | 1,018,338 | 761.41M |
| 64 | ALMS | Alumis Inc. | 3.50B | 4.69% | 1,225,339 | 22.12M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.40B | 0.56% | 2,016,401 | - |
| 66 | SYRE | Spyre Therapeutics, Inc. | 3.26B | 1.22% | 650,850 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.26B | 11.81% | 5,746,950 | - |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.14B | 2.23% | 673,846 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | -1.97% | 861,244 | 451.36M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.08B | 4.82% | 1,562,471 | 247.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -0.97% | 983,237 | 218.71M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -0.93% | 1,309,453 | 376.07M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.03B | -0.08% | 1,335,732 | 588.99M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.98B | -1.55% | 1,206,249 | 70.85M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.87B | 3.28% | 2,239,906 | - |
| 76 | TLX | Telix Pharmaceuticals Limited | 2.66B | 5.47% | 331,873 | 803.79M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.64B | -1.21% | 868,342 | 490.73M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.59B | -5.58% | 1,341,434 | 139.74M |
| 79 | WVE | Wave Life Sciences Ltd. | 2.59B | 3.46% | 1,829,850 | 42.73M |
| 80 | IRON | Disc Medicine, Inc. | 2.53B | 3.04% | 463,745 | - |
| 81 | APLS | Apellis Pharmaceuticals, Inc. | 2.51B | -1.75% | 1,333,166 | 1.00B |
| 82 | IMNM | Immunome, Inc. | 2.47B | 2.48% | 1,029,118 | 6.94M |
| 83 | MAZE | Maze Therapeutics, Inc. | 2.46B | 13.30% | 1,289,582 | 2.50M |
| 84 | TNGX | Tango Therapeutics, Inc. | 2.35B | 0.30% | 2,080,800 | 62.38M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | 4.37% | 3,639,968 | - |
| 86 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | -2.88% | 1,839,257 | 276.98M |
| 87 | GLPG | Galapagos NV | 2.21B | 0.45% | 81,202 | 1.31B |
| 88 | AAPG | Ascentage Pharma Group International | 2.21B | 3.38% | 3,264 | 54.52M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | 1.02% | 1,138,357 | 673.00M |
| 90 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | -0.23% | 7,286,967 | 158.18M |
| 91 | STOK | Stoke Therapeutics, Inc. | 2.19B | 0.10% | 1,091,281 | 205.63M |
| 92 | ZLAB | Zai Lab Limited | 2.18B | 1.78% | 333,117 | 460.16M |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.15B | -0.70% | 4,639,783 | 51.95M |
| 94 | IOVA | Iovance Biotherapeutics, Inc. | 2.14B | -3.88% | 19,787,868 | 263.50M |
| 95 | SNDX | Syndax Pharmaceuticals, Inc. | 2.13B | 1.17% | 1,785,779 | 172.35M |
| 96 | SLNO | Soleno Therapeutics, Inc. | 2.10B | 2.11% | 972,433 | 190.41M |
| 97 | CLDX | Celldex Therapeutics, Inc. | 2.07B | 1.37% | 1,079,264 | 1.55M |
| 98 | MESO | Mesoblast Limited | 2.02B | 2.01% | 258,066 | 65.38M |
| 99 | NKTR | Nektar Therapeutics | 2.02B | 4.22% | 577,892 | 62.60M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | 2.99% | 864,150 | 283.06M |
| 101 | RLAY | Relay Therapeutics, Inc. | 1.91B | 5.42% | 5,667,791 | 15.36M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 1.91B | 3.96% | 254,821 | - |
| 103 | DFTX | Definium Therapeutics, Inc. | 1.90B | 3.81% | 2,141,323 | - |
| 104 | MANE | Veradermics, Incorporated | 1.89B | -1.31% | 276,379 | - |
| 105 | ZYME | Zymeworks Inc. | 1.88B | 4.99% | 1,697,914 | 105.97M |
| 106 | TYRA | Tyra Biosciences, Inc. | 1.87B | 2.93% | 831,630 | - |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 0.11% | 2,732,288 | 2.20B |
| 108 | NBTX | Nanobiotix S.A. | 1.85B | -3.69% | 101,339 | 11.93M |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | -1.99% | 10,074,028 | 74.68M |
| 110 | ELVN | Enliven Therapeutics, Inc. | 1.81B | 1.72% | 976,741 | - |
| 111 | ANAB | AnaptysBio, Inc. | 1.78B | 3.87% | 527,920 | 234.60M |
| 112 | NVAX | Novavax, Inc. | 1.74B | 1.33% | 3,609,631 | 1.12B |
| 113 | CAPR | Capricor Therapeutics, Inc. | 1.73B | 9.04% | 4,810,381 | 11.13M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.71B | 1.52% | 255,408 | - |
| 115 | VCEL | Vericel Corporation | 1.70B | -2.11% | 507,149 | 276.26M |
| 116 | IMCR | Immunocore Holdings plc | 1.69B | -0.21% | 158,646 | 400.02M |
| 117 | OCS | Oculis Holding AG | 1.69B | 4.49% | 2,016,841 | 1.51M |
| 118 | PHVS | Pharvaris N.V. | 1.68B | -2.38% | 210,183 | - |
| 119 | HRMY | Harmony Biosciences Holdings, Inc. | 1.66B | 0.60% | 491,197 | 868.45M |
| 120 | INVA | Innoviva, Inc. | 1.66B | 0.40% | 626,534 | 411.33M |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | -0.95% | 526,640 | 54.03M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.64B | 2.58% | 1,040,556 | 83.98M |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.63B | 0.12% | 340,603 | - |
| 124 | NUVB | Nuvation Bio Inc. | 1.61B | -0.85% | 4,000,015 | 62.90M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -3.02% | 2,828,148 | 67.67M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.58B | 0.82% | 3,246,469 | 68.56M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.56B | 0.33% | 824,328 | 31.89M |
| 128 | KOD | Kodiak Sciences Inc. | 1.56B | -2.37% | 458,524 | - |
| 129 | BHVN | Biohaven Ltd. | 1.54B | 0.59% | 4,160,482 | - |
| 130 | ATAI | AtaiBeckley Inc. | 1.51B | 6.43% | 10,012,015 | 4.09M |
| 131 | TRVI | Trevi Therapeutics, Inc. | 1.51B | 0.51% | 1,605,547 | - |
| 132 | ARDX | Ardelyx, Inc. | 1.50B | -0.81% | 2,681,637 | 407.32M |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.42B | -2.98% | 710,751 | - |
| 134 | IMTX | Immatics N.V. | 1.41B | 5.00% | 918,214 | 56.67M |
| 135 | CRVS | Corvus Pharmaceuticals, Inc. | 1.41B | 5.60% | 1,460,152 | - |
| 136 | ZBIO | Zenas BioPharma, Inc. | 1.39B | -0.84% | 323,907 | 15.00M |
| 137 | SVRA | Savara Inc. | 1.39B | 3.31% | 1,060,030 | - |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | -2.15% | 659,470 | 181.54M |
| 139 | MBX | MBX Biosciences, Inc. | 1.37B | 3.83% | 623,369 | - |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.32B | 0.11% | 754,593 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.30B | 1.83% | 901,746 | - |
| 142 | DBVT | DBV Technologies S.A. | 1.30B | 2.79% | 293,052 | 5.50M |
| 143 | EYPT | EyePoint, Inc. | 1.29B | -1.47% | 1,161,823 | 31.37M |
| 144 | IVA | Inventiva S.A. | 1.26B | 3.13% | 447,482 | 19.93M |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | 8.07% | 1,799,872 | - |
| 146 | SEPN | Septerna, Inc. | 1.26B | -3.58% | 245,392 | 45.95M |
| 147 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | -0.44% | 1,406,190 | 6.31M |
| 148 | PGEN | Precigen, Inc. | 1.24B | - | 2,338,438 | 6.31M |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.24B | -1.50% | 3,777,760 | - |
| 150 | QURE | uniQure N.V. | 1.14B | 1.50% | 3,572,691 | 16.10M |
| 151 | AVBP | ArriVent BioPharma, Inc. | 1.12B | 2.10% | 1,023,362 | - |
| 152 | PHAR | Pharming Group N.V. | 1.11B | 4.25% | 31,763 | 362.27M |
| 153 | ABCL | AbCellera Biologics Inc. | 1.08B | 1.42% | 2,187,743 | 75.13M |
| 154 | GERN | Geron Corporation | 1.04B | 0.62% | 21,640,582 | 183.88M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.04B | -0.32% | 219,604 | 1.40M |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | 1.00B | 3.93% | 1,880,701 | 291.85M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.00B | 2.77% | 2,248,107 | 850.00K |
| 158 | AKTS | Aktis Oncology, Inc. | 996.87M | -0.42% | 203,397 | 5.56M |
| 159 | VALN | Valneva SE | 996.75M | 7.90% | 26,640 | 211.09M |
| 160 | SLS | SELLAS Life Sciences Group, Inc. | 991.04M | -2.35% | 6,636,297 | - |
| 161 | GHRS | GH Research PLC | 977.58M | -1.38% | 458,782 | - |
| 162 | URGN | UroGen Pharma Ltd. | 946.87M | -2.31% | 474,196 | 109.79M |
| 163 | KALV | KalVista Pharmaceuticals, Inc. | 932.07M | 6.59% | 1,664,127 | 1.43M |
| 164 | ANNX | Annexon, Inc. | 906.26M | 8.77% | 2,222,592 | - |
| 165 | ABUS | Arbutus Biopharma Corporation | 905.85M | -0.21% | 2,201,556 | 14.61M |
| 166 | CGEM | Cullinan Therapeutics, Inc. | 902.44M | -2.61% | 991,994 | - |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 899.74M | -3.58% | 1,881,220 | 185.74M |
| 168 | SGP | SpyGlass Pharma, Inc. | 893.57M | -1.11% | 309,587 | - |
| 169 | ARVN | Arvinas, Inc. | 884.58M | 3.44% | 741,504 | 262.60M |
| 170 | SPRY | ARS Pharmaceuticals, Inc. | 879.77M | -2.10% | 1,271,259 | 84.28M |
| 171 | XNCR | Xencor, Inc. | 878.60M | 0.93% | 931,932 | 125.58M |
| 172 | SANA | Sana Biotechnology, Inc. | 877.99M | -1.20% | 2,428,685 | - |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 875.45M | - | 726,139 | 175.11M |
| 174 | EVMN | Evommune, Inc. | 864.44M | -2.48% | 339,203 | 13.00M |
| 175 | JANX | Janux Therapeutics, Inc. | 855.90M | 0.64% | 775,728 | 10.00M |
| 176 | FTRE | Fortrea Holdings Inc. | 836.83M | -8.95% | 2,903,607 | 2.72B |
| 177 | OMER | Omeros Corporation | 830.24M | 3.72% | 815,698 | - |
| 178 | MPLT | MapLight Therapeutics, Inc. | 827.88M | -4.14% | 154,904 | - |
| 179 | CTMX | CytomX Therapeutics, Inc. | 826.84M | -2.98% | 2,174,083 | 113.63M |
| 180 | KURA | Kura Oncology, Inc. | 817.93M | -1.38% | 1,608,559 | 67.48M |
| 181 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 815.53M | -1.16% | 153,435 | - |
| 182 | DRUG | Bright Minds Biosciences Inc. | 809.93M | -1.03% | 112,477 | - |
| 183 | MNKD | MannKind Corporation | 804.14M | -2.61% | 4,987,716 | 348.97M |
| 184 | EIKN | Eikon Therapeutics, Inc. | 756.86M | -5.97% | 168,551 | - |
| 185 | PROK | ProKidney Corp. | 746.07M | 3.77% | 884,190 | 744.00K |
| 186 | GYRE | Gyre Therapeutics, Inc. | 738.03M | -0.49% | 114,966 | 107.27M |
| 187 | PRME | Prime Medicine, Inc. | 717.17M | -1.46% | 2,255,678 | 4.63M |
| 188 | JBIO | Jade Biosciences, Inc. | 714.10M | 0.35% | 989,715 | - |
| 189 | TBPH | Theravance Biopharma, Inc. | 710.93M | 0.21% | 501,069 | 80.33M |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 703.31M | -1.19% | 3,522,092 | 49.80M |
| 191 | REPL | Replimune Group, Inc. | 679.57M | -4.63% | 1,654,534 | - |
| 192 | MDXG | MiMedx Group, Inc. | 678.95M | 1.33% | 894,925 | 418.63M |
| 193 | AGMB | AgomAb Therapeutics NV | 670.13M | -4.71% | 156,531 | - |
| 194 | VOR | Vor Biopharma Inc. | 664.32M | 3.49% | 758,930 | - |
| 195 | ZURA | Zura Bio Limited | 654.64M | -1.99% | 573,389 | - |
| 196 | ZVRA | Zevra Therapeutics, Inc. | 649.35M | 21.27% | 9,386,907 | 106.47M |
| 197 | ANRO | Alto Neuroscience, Inc. | 648.67M | -5.05% | 199,441 | - |
| 198 | SLDB | Solid Biosciences Inc. | 637.31M | 2.00% | 2,431,446 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 624.61M | 5.29% | 919,347 | 27.42M |
| 200 | TECX | Tectonic Therapeutic, Inc. | 624.14M | -2.24% | 451,128 | - |
| 201 | DSGN | Design Therapeutics, Inc. | 616.11M | -3.66% | 234,324 | - |
| 202 | LRMR | Larimar Therapeutics, Inc. | 609.19M | -1.41% | 2,502,737 | - |
| 203 | ALLO | Allogene Therapeutics, Inc. | 609.02M | 8.40% | 4,590,630 | 22.00K |
| 204 | LBRX | LB Pharmaceuticals Inc | 607.68M | -1.31% | 215,061 | - |
| 205 | ADCT | ADC Therapeutics SA | 594.61M | 13.48% | 1,564,695 | 81.36M |
| 206 | TENX | Tenax Therapeutics, Inc. | 588.68M | 31.67% | 2,131,300 | - |
| 207 | DRTS | Alpha Tau Medical Ltd. | 583.21M | 1.94% | 295,413 | - |
| 208 | OCGN | Ocugen, Inc. | 580.38M | 6.63% | 4,795,780 | 4.41M |
| 209 | RCKT | Rocket Pharmaceuticals, Inc. | 575.42M | 3.72% | 3,897,933 | - |
| 210 | VNDA | Vanda Pharmaceuticals Inc. | 565.07M | 10.14% | 3,811,426 | 216.11M |
| 211 | VSTM | Verastem, Inc. | 561.27M | 1.43% | 1,047,464 | 30.91M |
| 212 | NMRA | Neumora Therapeutics, Inc. | 554.00M | 1.24% | 1,074,846 | - |
| 213 | IMMX | Immix Biopharma, Inc. | 548.03M | 2.67% | 830,891 | - |
| 214 | YDES | YD Bio Limited | 544.98M | -1.90% | 11,780 | 510.36K |
| 215 | LYEL | Lyell Immunopharma, Inc. | 544.48M | 0.51% | 117,472 | 41.00K |
| 216 | FULC | Fulcrum Therapeutics, Inc. | 533.47M | 0.88% | 1,163,965 | 80.00M |
| 217 | CRMD | CorMedix Inc. | 531.22M | 2.44% | 1,821,427 | 311.71M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 527.31M | 9.88% | 934,676 | - |
| 219 | PRTA | Prothena Corporation plc | 525.95M | -0.41% | 628,374 | 9.68M |
| 220 | LXEO | Lexeo Therapeutics, Inc. | 525.51M | -3.23% | 1,431,612 | - |
| 221 | RIGL | Rigel Pharmaceuticals, Inc. | 525.38M | 1.32% | 506,944 | 294.28M |
| 222 | IVVD | Invivyd, Inc. | 517.15M | -3.17% | 3,309,435 | 53.43M |
| 223 | RGNX | REGENXBIO Inc. | 510.97M | -4.62% | 1,112,617 | 170.44M |
| 224 | FBRX | Forte Biosciences, Inc. | 504.09M | 1.04% | 275,840 | - |
| 225 | ALT | Altimmune, Inc. | 502.07M | -0.52% | 3,565,682 | 41.00K |
| 226 | CTNM | Contineum Therapeutics, Inc. | 500.68M | -0.96% | 254,719 | - |
| 227 | IPSC | Century Therapeutics, Inc. | 497.62M | -5.78% | 1,805,840 | 113.34M |
| 228 | RLMD | Relmada Therapeutics, Inc. | 485.47M | -7.67% | 4,250,171 | - |
| 229 | AVIR | Atea Pharmaceuticals, Inc. | 482.02M | -1.63% | 1,077,755 | - |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 481.05M | 2.56% | 252,460 | - |
| 231 | TRDA | Entrada Therapeutics, Inc. | 475.20M | 3.94% | 273,256 | 25.42M |
| 232 | ASMB | Assembly Biosciences, Inc. | 468.19M | 1.61% | 83,179 | 37.19M |
| 233 | ENGN | enGene Holdings Inc. | 464.91M | -1.56% | 3,128,222 | - |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 452.44M | 1.60% | 574,998 | 120.00K |
| 235 | LCTX | Lineage Cell Therapeutics, Inc. | 450.85M | 2.26% | 1,357,878 | 14.56M |
| 236 | ACRS | Aclaris Therapeutics, Inc. | 442.58M | 8.26% | 10,079,399 | 7.83M |
| 237 | UPB | Upstream Bio, Inc. | 438.79M | 0.74% | 653,690 | 2.80M |
| 238 | ARMP | Armata Pharmaceuticals, Inc. | 435.43M | 3.01% | 46,033 | 5.05M |
| 239 | VTVT | vTv Therapeutics Inc. | 434.56M | -4.11% | 104,868 | 17.00K |
| 240 | AVXL | Anavex Life Sciences Corp. | 430.00M | -3.13% | 701,337 | - |
| 241 | STTK | Shattuck Labs, Inc. | 426.52M | -1.00% | 434,370 | 1.00M |
| 242 | DMAC | DiaMedica Therapeutics Inc. | 425.95M | 2.05% | 190,742 | - |
| 243 | AUTL | Autolus Therapeutics plc | 425.83M | -1.23% | 1,280,576 | 51.13M |
| 244 | PEPG | PepGen Inc. | 425.75M | 10.59% | 736,912 | - |
| 245 | BNTC | Benitec Biopharma Inc. | 420.31M | -2.23% | 216,864 | - |
| 246 | NAGE | Niagen Bioscience, Inc. | 418.89M | 2.15% | 1,947,858 | 129.42M |
| 247 | STRO | Sutro Biopharma, Inc. | 416.74M | 1.80% | 179,620 | 105.65M |
| 248 | CBIO | Crescent Biopharma, Inc. | 416.50M | 4.33% | 444,247 | 10.84M |
| 249 | IMMP | Immutep Limited | 408.45M | - | 5 | 5.28M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 407.45M | 12.29% | 1,999,170 | 33.98M |
| 251 | PRTC | PureTech Health plc | 407.35M | 5.61% | 11,349 | 6.39M |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 404.82M | 0.43% | 84,053 | 66.98M |
| 253 | MNPR | Monopar Therapeutics Inc. | 391.00M | 0.76% | 106,090 | - |
| 254 | ABSI | Absci Corporation | 381.94M | 1.20% | 2,085,854 | 2.82M |
| 255 | CADL | Candel Therapeutics, Inc. | 374.29M | -0.39% | 1,654,302 | - |
| 256 | LENZ | LENZ Therapeutics, Inc. | 373.60M | -2.93% | 419,080 | 17.50M |
| 257 | NBP | NovaBridge Biosciences | 373.54M | -7.56% | 743,414 | - |
| 258 | GLSI | Greenwich LifeSciences, Inc. | 373.24M | 4.58% | 196,848 | - |
| 259 | DNA | Ginkgo Bioworks Holdings, Inc. | 369.03M | -4.08% | 877,217 | 170.16M |
| 260 | BCYC | Bicycle Therapeutics plc | 367.65M | -1.49% | 497,773 | 28.34M |
| 261 | IMRX | Immuneering Corporation | 363.35M | - | 593,976 | - |
| 262 | AURA | Aura Biosciences, Inc. | 358.16M | -0.53% | 341,428 | - |
| 263 | NGNE | Neurogene Inc. | 357.35M | -2.25% | 98,498 | 925.00K |
| 264 | CLYM | Climb Bio, Inc. | 350.14M | 1.10% | 705,035 | - |
| 265 | NERV | Minerva Neurosciences, Inc. | 343.60M | -0.75% | 356,362 | - |
| 266 | IRD | Opus Genetics, Inc. | 334.48M | 1.68% | 1,553,087 | 14.20M |
| 267 | RZLT | Rezolute, Inc. | 333.43M | -1.53% | 1,586,923 | - |
| 268 | ANL | Adlai Nortye Ltd. | 328.41M | 1.25% | 210,690 | -1.35M |
| 269 | XOMA | XOMA Royalty Corporation | 324.32M | -0.62% | 176,558 | 47.11M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 321.61M | 0.18% | 246,382 | 24.52M |
| 271 | CABA | Cabaletta Bio, Inc. | 319.60M | 1.53% | 2,026,365 | - |
| 272 | CAMP | Camp4 Therapeutics Corporation | 314.11M | -3.66% | 471,917 | 3.50M |
| 273 | AVTX | Avalo Therapeutics, Inc. | 313.33M | -2.22% | 639,659 | 192.00K |
| 274 | TARA | Protara Therapeutics, Inc. | 308.82M | -0.70% | 1,256,553 | - |
| 275 | PBYI | Puma Biotechnology, Inc. | 308.31M | -2.57% | 398,009 | 228.37M |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 307.55M | -3.19% | 208,171 | - |
| 277 | CCCC | C4 Therapeutics, Inc. | 304.44M | -13.09% | 3,437,154 | 35.95M |
| 278 | ALDX | Aldeyra Therapeutics, Inc. | 301.52M | -4.75% | 1,610,446 | - |
| 279 | ACIU | AC Immune SA | 300.79M | 6.29% | 295,956 | 5.48M |
| 280 | VYGR | Voyager Therapeutics, Inc. | 298.00M | 21.65% | 5,134,241 | 40.37M |
| 281 | PRLD | Prelude Therapeutics Incorporated | 296.63M | 16.50% | 425,037 | 12.14M |
| 282 | SLN | Silence Therapeutics plc | 296.16M | 1.29% | 386,700 | 559.00K |
| 283 | CHRS | Coherus Oncology, Inc. | 292.29M | 1.04% | 2,424,905 | 42.17M |
| 284 | CLLS | Cellectis S.A. | 291.00M | 8.47% | 41,528 | 82.55M |
| 285 | OABI | OmniAb, Inc. | 288.12M | 2.05% | 336,722 | 18.67M |
| 286 | HELP | Cybin Inc. | 287.21M | 3.99% | 940,247 | - |
| 287 | PALI | Palisade Bio, Inc. | 286.09M | 10.34% | 4,642,249 | - |
| 288 | PLYX | Polaryx Therapeutics, Inc. | 282.64M | 69.60% | 25,032,571 | - |
| 289 | ABEO | Abeona Therapeutics Inc. | 278.54M | -0.39% | 2,087,146 | 400.00K |
| 290 | OVID | Ovid Therapeutics Inc. | 277.29M | -0.47% | 4,472,180 | 6.61M |
| 291 | ENLV | Enlivex Ltd. | 275.36M | - | 124,325 | - |
| 292 | FENC | Fennec Pharmaceuticals Inc. | 269.47M | 3.95% | 111,700 | 38.79M |
| 293 | ALXO | ALX Oncology Holdings Inc. | 268.48M | -4.23% | 446,238 | - |
| 294 | CNTX | Context Therapeutics Inc. | 268.29M | 0.69% | 804,148 | - |
| 295 | CBUS | Cibus, Inc. | 268.20M | 7.88% | 599,178 | 3.79M |
| 296 | IKT | Inhibikase Therapeutics, Inc. | 266.73M | 3.17% | 1,886,188 | 1.00 |
| 297 | ALEC | Alector, Inc. | 262.66M | 8.68% | 1,822,947 | 21.05M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 262.00M | -0.64% | 175,024 | 2.82M |
| 299 | SRZN | Surrozen, Inc. | 258.61M | 1.24% | 101,232 | 3.60M |
| 300 | EDIT | Editas Medicine, Inc. | 258.38M | 13.79% | 4,401,727 | 40.52M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 255.64M | 6.28% | 94,856 | - |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 247.10M | 4.37% | 21,398 | 18.97M |
| 303 | CNTN | Canton Strategic Holdings, Inc. | 240.08M | 4.72% | 489,529 | - |
| 304 | HUMA | Humacyte, Inc. | 239.32M | 3.33% | 6,203,171 | 1.57M |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 233.22M | 0.69% | 632,797 | 61.84M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 230.12M | - | 2,017,863 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 228.33M | 2.03% | 657,324 | 244.06M |
| 308 | ACHV | Achieve Life Sciences, Inc. | 227.84M | 1.42% | 378,767 | - |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 226.65M | -5.21% | 398,473 | 2.80M |
| 310 | ELTX | Elicio Therapeutics, Inc. | 225.43M | 9.51% | 282,816 | - |
| 311 | MDWD | MediWound Ltd. | 223.13M | -0.69% | 69,050 | 16.96M |
| 312 | MGNX | MacroGenics, Inc. | 218.00M | 45.34% | 14,023,502 | 149.50M |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.58M | 3.53% | 484,374 | 82.03M |
| 314 | CGEN | Compugen Ltd. | 211.80M | 4.19% | 372,165 | 72.76M |
| 315 | SABS | SAB Biotherapeutics, Inc. | 208.90M | 6.77% | 2,027,846 | 114.70K |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 203.53M | 7.01% | 376,137 | - |
| 317 | ZNTL | Zentalis Pharmaceuticals, Inc. | 198.14M | 23.39% | 2,081,251 | 26.87M |
| 318 | GALT | Galectin Therapeutics Inc. | 197.29M | -8.66% | 686,142 | - |
| 319 | CRBU | Caribou Biosciences, Inc. | 196.17M | 3.05% | 2,310,052 | 11.16M |
| 320 | PMN | ProMIS Neurosciences, Inc. | 194.51M | -8.75% | 39,150 | - |
| 321 | TNYA | Tenaya Therapeutics, Inc. | 193.77M | -6.54% | 7,439,658 | - |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 189.93M | -1.23% | 276,414 | 14.38M |
| 323 | PRQR | ProQR Therapeutics N.V. | 189.62M | -4.76% | 331,381 | 18.86M |
| 324 | MENS | Jyong Biotech Ltd. | 187.64M | 3.83% | 94,042 | - |
| 325 | NTHI | NeOnc Technologies Holdings, Inc. | 187.24M | -3.19% | 28,212 | 59.99K |
| 326 | HRTX | Heron Therapeutics, Inc. | 186.31M | -0.83% | 1,485,482 | 154.90M |
| 327 | KLRS | Kalaris Therapeutics, Inc. | 186.28M | -0.40% | 31,820 | - |
| 328 | VXRT | Vaxart, Inc. | 185.71M | -3.27% | - | 148.20M |
| 329 | NKTX | Nkarta, Inc. | 182.55M | -0.39% | 754,154 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 181.29M | 1.65% | 274,045 | 10.30M |
| 331 | MIST | Milestone Pharmaceuticals Inc. | 180.82M | 6.59% | 1,618,246 | - |
| 332 | MOLN | Molecular Partners AG | 180.68M | -0.41% | 3,385 | 856.30K |
| 333 | SGMT | Sagimet Biosciences Inc. | 179.84M | 2.79% | 239,567 | - |
| 334 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 178.07M | 5.13% | 417,611 | - |
| 335 | TLSA | Tiziana Life Sciences Ltd | 174.84M | -0.72% | 41,283 | - |
| 336 | IMUX | Immunic, Inc. | 168.30M | 3.20% | 4,453,798 | - |
| 337 | RANI | Rani Therapeutics Holdings, Inc. | 161.62M | -3.62% | 1,066,372 | 1.20M |
| 338 | CNTB | Connect Biopharma Holdings Limited | 155.97M | 5.28% | 255,381 | 762.00K |
| 339 | SGMO | Sangamo Therapeutics, Inc. | 153.84M | 0.90% | 2,652,139 | 32.88M |
| 340 | IPHA | Innate Pharma S.A. | 153.02M | 2.50% | 16,706 | 14.84M |
| 341 | KPTI | Karyopharm Therapeutics Inc. | 150.97M | -3.06% | 605,333 | 146.07M |
| 342 | FATE | Fate Therapeutics, Inc. | 149.98M | -3.01% | 1,238,726 | 6.65M |
| 343 | ANTX | AN2 Therapeutics, Inc. | 149.62M | 4.00% | 4,240,016 | - |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 149.37M | -1.42% | 439,659 | - |
| 345 | ARTV | Artiva Biotherapeutics, Inc. | 149.23M | 6.48% | 144,830 | 251.00K |
| 346 | CRDF | Cardiff Oncology, Inc. | 138.10M | 1.51% | 556,556 | 593.00K |
| 347 | ADAG | Adagene Inc. | 138.09M | -3.93% | 723,611 | 103.20K |
| 348 | SPRO | Spero Therapeutics, Inc. | 138.03M | 5.60% | 540,284 | 40.55M |
| 349 | ORMP | Oramed Pharmaceuticals Inc. | 132.54M | 2.15% | 160,917 | 2.00M |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 129.33M | 4.13% | 806,418 | 70.00M |
| 351 | DTIL | Precision BioSciences, Inc. | 128.78M | 13.59% | 480,142 | 698.00K |
| 352 | ACOG | Alpha Cognition Inc. | 128.06M | 0.34% | 14,152 | 7.43M |
| 353 | AARD | Aardvark Therapeutics, Inc. | 126.07M | -4.93% | 601,674 | - |
| 354 | GNLX | Genelux Corporation | 124.00M | -1.06% | 111,331 | 8.00K |
| 355 | EQ | Equillium, Inc. | 119.96M | -2.48% | 402,074 | 4.39M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 118.86M | - | 561,334 | 182.34K |
| 357 | GOSS | Gossamer Bio, Inc. | 117.37M | -8.68% | 9,538,744 | 44.05M |
| 358 | SAVA | Cassava Sciences, Inc. | 114.97M | 12.26% | 2,089,957 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 114.89M | 1.24% | 136,116 | 3.99M |
| 360 | AGEN | Agenus Inc. | 114.61M | 6.98% | 844,602 | 106.83M |
| 361 | KRRO | Korro Bio, Inc. | 113.89M | -6.67% | 253,194 | 7.37M |
| 362 | CDXS | Codexis, Inc. | 112.00M | -0.80% | 925,415 | 52.93M |
| 363 | ONCY | Oncolytics Biotech Inc. | 109.76M | -3.77% | 1,019,252 | - |
| 364 | HURA | TuHURA Biosciences, Inc. | 109.30M | 6.51% | 741,863 | - |
| 365 | GANX | Gain Therapeutics, Inc. | 108.85M | -3.41% | 773,364 | - |
| 366 | FBIO | Fortress Biotech, Inc. | 104.29M | -0.30% | 268,188 | 62.30M |
| 367 | BMEA | Biomea Fusion, Inc. | 103.93M | 3.52% | 1,722,211 | - |
| 368 | DWTX | Dogwood Therapeutics, Inc. | 103.22M | 1.31% | 106,697 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 103.06M | 0.86% | 4,606 | - |
| 370 | SEER | Seer, Inc. | 99.86M | -2.21% | 1,083,956 | 16.58M |
| 371 | ANIX | Anixa Biosciences, Inc. | 99.47M | - | 87,779 | - |
| 372 | CGTX | Cognition Therapeutics, Inc. | 98.87M | 3.70% | 839,486 | - |
| 373 | PYXS | Pyxis Oncology, Inc. | 96.51M | 3.33% | 754,315 | 2.82M |
| 374 | VRCA | Verrica Pharmaceuticals Inc. | 95.62M | 5.28% | 272,035 | 30.83M |
| 375 | VANI | Vivani Medical, Inc. | 93.43M | - | 104,732 | - |
| 376 | KZIA | Kazia Therapeutics Limited | 92.84M | 3.65% | 96,049 | 1.20M |
| 377 | ATYR | aTyr Pharma, Inc. | 91.76M | 4.02% | 1,124,919 | 190.00K |
| 378 | MAIA | MAIA Biotechnology, Inc. | 87.99M | 0.67% | 1,222,251 | - |
| 379 | OKYO | OKYO Pharma Limited | 87.33M | -0.58% | 53,842 | - |
| 380 | PMVP | PMV Pharmaceuticals, Inc. | 86.39M | -0.61% | 631,145 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 86.15M | 1.09% | 84,471 | 697.00K |
| 382 | PLRX | Pliant Therapeutics, Inc. | 85.41M | 5.30% | 654,678 | - |
| 383 | QTTB | Q32 Bio Inc. | 83.69M | 17.45% | 454,282 | 53.74M |
| 384 | PYPD | PolyPid Ltd. | 82.44M | 3.35% | 51,769 | - |
| 385 | IBIO | iBio, Inc. | 82.21M | -4.80% | 620,230 | 300.00K |
| 386 | CING | Cingulate Inc. | 81.99M | 14.89% | 493,680 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 81.89M | 9.80% | 1,115 | 7.41M |
| 388 | MCRB | Seres Therapeutics, Inc. | 80.97M | -3.97% | 44,375 | 351.00K |
| 389 | CSBR | Champions Oncology, Inc. | 80.44M | -2.97% | 15,334 | 58.42M |
| 390 | ACET | Adicet Bio, Inc. | 76.10M | -1.05% | 181,110 | - |
| 391 | GUTS | Fractyl Health, Inc. | 74.58M | -0.55% | 1,753,370 | 3.00K |
| 392 | COEP | Coeptis Therapeutics Holdings, Inc. | 71.71M | -0.82% | 52,703 | 501.00K |
| 393 | XBIT | XBiotech Inc. | 71.04M | -0.85% | 14,020 | - |
| 394 | MNOV | MediciNova, Inc. | 69.40M | 2.17% | 13,694 | 409.66K |
| 395 | ANVS | Annovis Bio, Inc. | 68.38M | 0.39% | 225,166 | - |
| 396 | ENTX | Entera Bio Ltd. | 68.33M | 12.03% | 101,292 | 124.00K |
| 397 | NRXS | NeurAxis, Inc. | 67.22M | 9.74% | 217,984 | 3.36M |
| 398 | TCRX | TScan Therapeutics, Inc. | 67.14M | -4.84% | 501,586 | 10.33M |
| 399 | MGX | Metagenomi Therapeutics, Inc. | 66.21M | 10.00% | 784,105 | 25.21M |
| 400 | ACTU | Actuate Therapeutics, Inc. | 66.01M | -3.57% | 49,440 | - |
| 401 | IMA | ImageneBio, Inc. | 64.65M | 2.53% | 50,417 | 800.00K |
| 402 | IBO | Impact BioMedical Inc. | 63.61M | -4.84% | 469,111 | 25.00K |
| 403 | MREO | Mereo BioPharma Group plc | 63.60M | 2.07% | 829,974 | 500.00K |
| 404 | INKT | MiNK Therapeutics, Inc. | 63.42M | 29.28% | 15,907,977 | - |
| 405 | EXOZ | eXoZymes, Inc. | 63.09M | 2.04% | 3,722 | -700.00 |
| 406 | IFRX | InflaRx N.V. | 63.00M | -2.23% | 265,196 | 73.73K |
| 407 | GRCE | Grace Therapeutics, Inc. | 61.12M | 0.51% | 257,159 | - |
| 408 | HYFT | MindWalk Holdings Corp. | 60.70M | 18.18% | 949,561 | 19.02M |
| 409 | TIL | Instil Bio, Inc. | 60.56M | 0.34% | 21,226 | - |
| 410 | BYSI | BeyondSpring Inc. | 60.45M | -0.68% | 12,147 | 1.88M |
| 411 | LONA | LeonaBio, Inc. | 60.03M | 4.21% | 67,048 | - |
| 412 | ICCC | ImmuCell Corporation | 59.97M | 2.31% | 13,639 | 27.64M |
| 413 | NRXP | NRx Pharmaceuticals, Inc. | 57.69M | 4.62% | 729,669 | 242.00K |
| 414 | EDSA | Edesa Biotech, Inc. | 57.60M | -3.36% | 1,865,113 | - |
| 415 | OSTX | OS Therapies Incorporated | 57.40M | -4.68% | 1,380,331 | - |
| 416 | KLTO | Klotho Neurosciences, Inc. | 56.21M | 10.38% | 4,922,291 | - |
| 417 | RADX | Radiopharm Theranostics Limited | 55.69M | 0.81% | 55,218 | 10.86M |
| 418 | ATHE | Alterity Therapeutics Limited | 54.37M | 1.97% | 9,902 | 4.43M |
| 419 | PSTV | Plus Therapeutics, Inc. | 53.51M | 2.47% | 2,737,121 | 5.26M |
| 420 | RLYB | Rallybio Corporation | 52.90M | -7.15% | 123,139 | 674.00K |
| 421 | ACRV | Acrivon Therapeutics, Inc. | 52.38M | 3.75% | 530,168 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 52.21M | 1.86% | 26,661 | - |
| 423 | ESLA | Estrella Immunopharma, Inc. | 51.28M | 8.93% | 103,826 | - |
| 424 | NTRB | Nutriband Inc. | 48.87M | -5.41% | 22,454 | 2.28M |
| 425 | OKUR | OnKure Therapeutics, Inc. | 47.96M | 4.12% | 215,148 | - |
| 426 | ATRA | Atara Biotherapeutics, Inc. | 45.35M | -5.84% | 644,240 | 151.93M |
| 427 | NXTC | NextCure, Inc. | 45.25M | 1.60% | 34,102 | - |
| 428 | LPCN | Lipocine Inc. | 45.03M | 2.92% | 150,129 | 1.98M |
| 429 | CRVO | CervoMed Inc. | 44.97M | 7.05% | 154,556 | 6.16M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | -2.26% | 107,760 | - |
| 431 | LSTA | Lisata Therapeutics, Inc. | 44.37M | -0.20% | 51,642 | 1.07M |
| 432 | ALGS | Aligos Therapeutics, Inc. | 43.93M | 1.00% | 34,299 | 2.19M |
| 433 | APLM | Apollomics, Inc. | 42.77M | -0.45% | 1,218 | 6.93M |
| 434 | LITS | Lite Strategy, Inc. | 42.54M | -2.50% | 320,593 | - |
| 435 | ATOS | Atossa Therapeutics, Inc. | 41.16M | 4.60% | 125,425 | - |
| 436 | XLO | Xilio Therapeutics, Inc. | 41.14M | 3.70% | 429,405 | 31.80M |
| 437 | CELU | Celularity Inc. | 40.08M | 11.20% | 7,013,423 | 40.58M |
| 438 | VERU | Veru Inc. | 39.64M | 0.41% | 50,037 | 16.89M |
| 439 | PTN | Palatin Technologies, Inc. | 38.46M | -2.24% | 19,528 | 8.96M |
| 440 | JSPR | Jasper Therapeutics, Inc. | 38.34M | 4.58% | 447,810 | - |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 37.96M | 1.69% | 86,366 | - |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 37.75M | 0.83% | 32,399 | 90.00K |
| 443 | PDSB | PDS Biotechnology Corporation | 37.58M | 0.25% | 171,965 | - |
| 444 | OTLK | Outlook Therapeutics, Inc. | 36.96M | -0.58% | 789,031 | 205.70K |
| 445 | ABVC | ABVC BioPharma, Inc. | 36.08M | - | 45,658 | 797.92K |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 35.93M | -3.77% | 32,806 | - |
| 447 | HOWL | Werewolf Therapeutics, Inc. | 35.92M | 1.00% | 386,596 | 1.14M |
| 448 | PLUR | Pluri Inc. | 34.17M | 0.89% | 6,741 | 1.34M |
| 449 | INMB | INmune Bio Inc. | 34.03M | -2.29% | 265,714 | 50.00K |
| 450 | NBY | NovaBay Pharmaceuticals, Inc. | 32.92M | 1.61% | 321,593 | 10.30M |
| 451 | RNTX | Rein Therapeutics Inc. | 32.86M | 4.17% | 144,708 | - |
| 452 | TPST | Tempest Therapeutics, Inc. | 32.35M | 0.42% | 83,009 | - |
| 453 | TVGN | Tevogen Bio Holdings Inc. | 31.54M | 0.52% | 34,755 | - |
| 454 | LTRN | Lantern Pharma Inc. | 30.87M | 0.73% | 22,004 | - |
| 455 | CUE | Cue Biopharma, Inc. | 30.21M | 2.99% | 1,622,478 | 7.10M |
| 456 | RNXT | RenovoRx, Inc. | 30.05M | 2.47% | 182,642 | 928.00K |
| 457 | DYAI | Dyadic International, Inc. | 30.04M | 3.75% | 70,495 | 3.34M |
| 458 | CVM | CEL-SCI Corporation | 29.94M | -4.39% | 18,611 | - |
| 459 | EVAX | Evaxion A/S | 29.86M | 16.23% | 49,143 | 7.53M |
| 460 | AEON | AEON Biopharma, Inc. | 29.10M | 7.48% | 62,040 | - |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 29.00M | 3.32% | 201,289 | - |
| 462 | KYNB | Kyntra Bio, Inc. | 28.84M | -2.86% | 13,214 | 8.30M |
| 463 | HYPD | Hyperion DeFi, Inc. | 27.63M | -3.24% | 170,709 | 345.32K |
| 464 | IGC | IGC Pharma, Inc. | 27.31M | -1.66% | 211,086 | 1.11M |
| 465 | PASG | Passage Bio, Inc. | 27.30M | -3.19% | 24,195 | - |
| 466 | BCTX | BriaCell Therapeutics Corp. | 27.09M | 1.33% | 174,800 | - |
| 467 | FBLG | FibroBiologics, Inc. | 26.77M | -1.02% | 845,677 | - |
| 468 | XCUR | Exicure, Inc. | 26.26M | 0.73% | 23,837 | 500.00K |
| 469 | SNTI | Senti Biosciences, Inc. | 26.11M | 2.12% | 93,889 | - |
| 470 | SKYE | Skye Bioscience, Inc. | 25.61M | 10.33% | 17,604,984 | - |
| 471 | BOLD | Boundless Bio, Inc. | 25.56M | 0.18% | 77,434 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 25.07M | 2.42% | 79,142 | 14.99M |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 24.21M | -0.65% | 290,726 | 789.00K |
| 474 | MRKR | Marker Therapeutics, Inc. | 23.51M | -4.08% | 99,403 | 4.69M |
| 475 | BRNS | Barinthus Biotherapeutics plc | 23.07M | 0.52% | 2,817 | 14.97M |
| 476 | LIXT | Lixte Biotechnology Holdings, Inc. | 22.39M | 2.39% | 30,732 | - |
| 477 | DARE | Daré Bioscience, Inc. | 21.29M | -2.61% | 32,863 | -57.13K |
| 478 | NNVC | NanoViricides, Inc. | 20.99M | -0.83% | 69,456 | - |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 20.83M | 10.97% | 1,830,644 | 3.94M |
| 480 | PLRZ | Polyrizon Ltd. | 20.66M | -0.15% | 13,866 | - |
| 481 | ALLR | Allarity Therapeutics, Inc. | 20.42M | 2.42% | 179,797 | - |
| 482 | GNTA | Genenta Science S.p.A. | 20.20M | 0.52% | 37,935 | - |
| 483 | VYNE | VYNE Therapeutics Inc. | 20.05M | 1.97% | 114,341 | 570.00K |
| 484 | INTS | Intensity Therapeutics, Inc. | 19.56M | -0.64% | 21,027 | - |
| 485 | IOBT | IO Biotech, Inc. | 19.12M | -5.11% | 1,917,642 | - |
| 486 | LGVN | Longeveron Inc. | 19.01M | 68.27% | 250,465,309 | 1.44M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 18.90M | 2.30% | 82,483 | - |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 18.71M | - | 34,161 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 18.12M | -0.21% | 164,806 | 522.00K |
| 490 | INAB | IN8bio, Inc. | 17.68M | 2.26% | 50,981 | - |
| 491 | SER | Serina Therapeutics, Inc. | 17.47M | 1.89% | 32,649 | 116.00K |
| 492 | HOTH | Hoth Therapeutics, Inc. | 15.59M | 1.48% | 397,366 | - |
| 493 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 15.25M | -9.38% | 420,805 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.68M | 3.40% | 55,525 | - |
| 495 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.46M | 1.87% | 6,231 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 14.29M | 1.65% | 342,775 | - |
| 497 | JUNS | Jupiter Neurosciences, Inc. | 14.09M | -3.51% | 408,552 | - |
| 498 | BCAB | BioAtla, Inc. | 13.97M | -8.99% | 1,251,557 | 11.00M |
| 499 | CRIS | Curis, Inc. | 13.83M | -1.94% | 96,010 | 11.65M |
| 500 | TRAW | Traws Pharma, Inc. | 13.82M | 3.59% | 88,307 | 2.85M |
| 501 | BCDA | BioCardia, Inc. | 13.48M | -0.78% | 36,287 | 3.00K |
| 502 | KAPA | Kairos Pharma, Ltd. | 13.33M | 1.41% | 184,956 | - |
| 503 | GTBP | GT Biopharma, Inc. | 13.14M | -0.14% | 711,312 | - |
| 504 | CLRB | Cellectar Biosciences, Inc. | 12.93M | 10.91% | 161,582 | - |
| 505 | OSRH | OSR Holdings, Inc. | 12.84M | -0.34% | 264,866 | -90.52K |
| 506 | SNGX | Soligenix, Inc. | 12.41M | 2.50% | 344,085 | 2.34K |
| 507 | CMMB | Chemomab Therapeutics Ltd. | 12.19M | -1.00% | 110,522 | - |
| 508 | GDTC | CytoMed Therapeutics Limited | 12.00M | -1.89% | 3,344 | 573.19K |
| 509 | PHGE | BiomX Inc. | 11.95M | 1.08% | 97,914 | - |
| 510 | NCEL | NewcelX Ltd. | 11.94M | -4.38% | 88,774 | - |
| 511 | BLRX | BioLineRx Ltd. | 11.87M | 1.14% | 5,470 | 12.74M |
| 512 | AKTX | Akari Therapeutics, Plc | 11.63M | 2.31% | 771,527 | - |
| 513 | QNTM | Quantum BioPharma Ltd. | 11.27M | -16.67% | 340,561 | - |
| 514 | LIMN | Liminatus Pharma, Inc. | 10.86M | 3.64% | 1,836,765 | - |
| 515 | CALC | CalciMedica, Inc. | 10.63M | -7.67% | 239,702 | - |
| 516 | IMNN | Imunon, Inc. | 10.51M | -0.96% | 16,985 | - |
| 517 | BIVI | BioVie Inc. | 10.33M | -1.44% | 76,827 | - |
| 518 | MBRX | Moleculin Biotech, Inc. | 9.72M | 0.51% | 134,214 | - |
| 519 | ICU | SeaStar Medical Holding Corporation | 9.70M | 1.89% | 42,547 | 881.00K |
| 520 | ITRM | Iterum Therapeutics plc | 9.61M | 1.73% | 1,141,760 | 390.00K |
| 521 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.11M | 2.67% | 332,085 | 15.78K |
| 522 | CLGN | CollPlant Biotechnologies Ltd. | 8.95M | -1.41% | 29,299 | 2.48M |
| 523 | RNAZ | TransCode Therapeutics, Inc. | 8.86M | -0.10% | 3,448 | - |
| 524 | NCNA | NuCana plc | 8.37M | 3.08% | 26,880 | - |
| 525 | KALA | KALA BIO, Inc. | 8.30M | 12.82% | 1,226,544 | - |
| 526 | ERNA | Ernexa Therapeutics Inc. | 8.18M | 6.68% | 5,476,218 | 1,000.00 |
| 527 | BOLT | Bolt Biotherapeutics, Inc. | 8.18M | 3.40% | 6,766 | 5.20M |
| 528 | TOVX | Theriva Biologics, Inc. | 8.16M | -2.79% | 906,394 | - |
| 529 | PULM | Pulmatrix, Inc. | 8.14M | 8.78% | 41,660 | 3.00K |
| 530 | ALZN | Alzamend Neuro, Inc. | 8.14M | 1.90% | 71,200 | - |
| 531 | KPRX | Kiora Pharmaceuticals, Inc. | 8.00M | 1.87% | 26,981 | 20.00K |
| 532 | TCRT | Alaunos Therapeutics, Inc. | 7.79M | -4.38% | 7,609 | 6.00K |
| 533 | GRDX | GridAI Technologies Corp. | 7.77M | 8.45% | 140,680 | - |
| 534 | MLEC | Moolec Science SA | 7.61M | 16.78% | 179,940 | 7.83M |
| 535 | IMRN | Immuron Limited | 7.47M | 4.41% | 2,979 | 4.99M |
| 536 | ACXP | Acurx Pharmaceuticals, Inc. | 7.39M | 48.34% | 34,350,018 | - |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 7.30M | -2.87% | 63,986 | - |
| 538 | MBIO | Mustang Bio, Inc. | 7.22M | 7.70% | 69,405 | - |
| 539 | CELZ | Creative Medical Technology Holdings, Inc. | 6.78M | 1.57% | 7,050 | 6.00K |
| 540 | ADXN | Addex Therapeutics Ltd | 6.76M | -2.08% | - | 198.82K |
| 541 | EVGN | Evogene Ltd. | 6.62M | 3.29% | 68,660 | 3.85M |
| 542 | PCSA | Processa Pharmaceuticals, Inc. | 6.62M | 4.29% | 13,393 | - |
| 543 | APM | Aptorum Group Limited | 6.45M | -0.93% | 27,892 | - |
| 544 | XTLB | XTL Biopharmaceuticals Ltd. | 6.45M | -9.83% | 93,157 | 968.00K |
| 545 | ASBP | Aspire Biopharma Holdings, Inc. | 6.13M | 1.67% | 269,605 | 1.94K |
| 546 | BRTX | BioRestorative Therapies, Inc. | 6.11M | 22.76% | 159,897,122 | 383.40K |
| 547 | XBIO | Xenetic Biosciences, Inc. | 6.05M | 14.29% | 106,154 | 2.86M |
| 548 | PPBT | Purple Biotech Ltd | 6.03M | -7.05% | 19,957 | - |
| 549 | SLXN | Silexion Therapeutics Corp | 5.88M | -4.08% | 32,685 | - |
| 550 | APRE | Aprea Therapeutics, Inc. | 5.81M | -1.63% | 86,396 | 488.24K |
| 551 | QNCX | Quince Therapeutics, Inc. | 5.79M | -2.35% | 35,714,274 | - |
| 552 | PBM | Psyence Biomedical Ltd. | 5.76M | -1.57% | 29,363 | - |
| 553 | CANF | Can-Fite BioPharma Ltd. | 5.63M | 2.94% | 84,003 | 560.00K |
| 554 | CYCN | Cyclerion Therapeutics, Inc. | 5.60M | -1.34% | 80,217 | 2.86M |
| 555 | APVO | Aptevo Therapeutics Inc. | 5.19M | -22.85% | 907,955 | - |
| 556 | GOVX | GeoVax Labs, Inc. | 5.07M | 0.52% | 72,775 | 3.35M |
| 557 | REVB | Revelation Biosciences, Inc. | 4.99M | 4.69% | 95,373 | - |
| 558 | MTVA | MetaVia Inc. | 4.97M | 7.64% | 105,072 | - |
| 559 | VIVS | VivoSim Labs, Inc. | 4.96M | 1.60% | 27,656 | 142.00K |
| 560 | LNAI | Lunai Bioworks Inc. | 4.83M | -9.27% | 697,003 | - |
| 561 | BGMS | Bio Green Med Solution, Inc. | 4.66M | 1.63% | 21,242 | 81.00K |
| 562 | GNPX | Genprex, Inc. | 4.64M | 1.01% | 476,974 | - |
| 563 | SILO | Silo Pharma, Inc. | 4.62M | 1.85% | 140,106 | 72.10K |
| 564 | DCOY | Decoy Therapeutics Inc. | 4.39M | -4.07% | 30,826 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 4.19M | - | 32,764 | - |
| 566 | OGEN | Oragenics, Inc. | 4.19M | 2.23% | 350,413 | - |
| 567 | GLMD | Galmed Pharmaceuticals Ltd. | 4.03M | -0.44% | 7,417 | - |
| 568 | GRI | GRI Bio, Inc. | 3.97M | 10.00% | 72,052 | - |
| 569 | MTNB | Matinas BioPharma Holdings, Inc. | 3.86M | -0.07% | 13,313 | - |
| 570 | AZTR | Azitra, Inc. | 3.32M | 0.99% | 1,647,407 | 7.50K |
| 571 | HCWB | HCW Biologics Inc. | 3.22M | -5.48% | 87,449 | 422.03K |
| 572 | XRTX | XORTX Therapeutics Inc. | 3.08M | 1.76% | 29,805 | - |
| 573 | DRMA | Dermata Therapeutics, Inc. | 3.03M | -4.51% | 105,242 | - |
| 574 | ARTL | Artelo Biosciences, Inc. | 2.87M | 15.38% | 123,242 | - |
| 575 | CDT | CDT Equity Inc. | 2.77M | -8.66% | 51,411 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 2.75M | -0.50% | 53,656 | - |
| 577 | CLDI | Calidi Biotherapeutics, Inc. | 2.65M | -1.50% | 501,167 | - |
| 578 | ADIL | Adial Pharmaceuticals, Inc. | 2.61M | 6.40% | 54,164 | - |
| 579 | SCNI | Scinai Immunotherapeutics Ltd. | 2.60M | 1.03% | 5,413 | 1.15M |
| 580 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.42M | -2.59% | 63,888 | 1.36M |
| 581 | ELAB | PMGC Holdings Inc. | 2.41M | 3.74% | 381,350 | 285.95K |
| 582 | LYRA | Lyra Therapeutics, Inc. | 2.31M | - | 14,487 | 600.00K |
| 583 | BBLG | Bone Biologics Corporation | 2.30M | 4.92% | 14,684 | - |
| 584 | SPRC | SciSparc Ltd. | 2.27M | -28.34% | 1,002,217 | 1.31M |
| 585 | PPCB | Propanc Biopharma, Inc. | 2.17M | -20.47% | 4,784,081 | - |
| 586 | JAGX | Jaguar Health, Inc. | 2.14M | -4.11% | 628,747 | 11.79M |
| 587 | CNSP | CNS Pharmaceuticals, Inc. | 2.08M | 10.93% | 117,855 | - |
| 588 | ENSC | Ensysce Biosciences, Inc. | 1.80M | -8.12% | 550,432 | 4.49M |
| 589 | CMND | Clearmind Medicine Inc. | 1.79M | -1.96% | 342,481 | - |
| 590 | VRAX | Virax Biolabs Group Limited | 1.50M | 1.30% | 79,732 | 2.99K |
| 591 | ONCO | Onconetix, Inc. | 899.58K | 9.77% | 121,522 | 1.22M |
| 592 | BDRX | Biodexa Pharmaceuticals Plc | 796.76K | -0.01% | 58,733 | 104.90K |
| 593 | ADTX | Aditxt, Inc. | 606.07K | -21.33% | 173,522 | 5.95K |